Literature DB >> 29465365

Polyarteritis nodosa revisited: a review of historical approaches, subphenotypes and a research agenda.

Omer Karadag1, David J Jayne2.   

Abstract

Polyarteritis nodosa (PAN) is a rare form of primary systemic vasculitis with heterogeneous presentations, treatments and disease course. Historical approaches to classification and diagnostic terminology are reviewed. Since differentiation of PAN from microscopic polyangiitis (MPA) and other ANCA vasculitides by the Chapel Hill conference statements, and with hepatitis associated PAN defined as a secondary vasculitis, the phenotyping and subclassification of PAN has received little attention. Monogenic disorders similar to PAN have been described (familial Mediterranean fever, Adenosine Deaminase-2 deficiency), and cutaneous PAN and single organ vasculitis, discussed. The overlapping phenotypes between PAN and other primary vasculitic syndromes and subphenotypes within PAN are explored. This work will underpin development of newer treatment regimens and future genetic and related aetiologic studies.

Entities:  

Mesh:

Year:  2018        PMID: 29465365

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  10 in total

Review 1.  Childhood- Versus Adult-Onset Primary Vasculitides: Are They Part of the Same Clinical Spectrum?

Authors:  Renato Ferrandiz-Espadin; Manuel Ferrandiz-Zavaler
Journal:  Curr Rheumatol Rep       Date:  2019-08-29       Impact factor: 4.592

Review 2.  Polyarteritis nodosa and deficiency of adenosine deaminase 2 - Shared genealogy, generations apart.

Authors:  Zhengping Huang; Tianwang Li; Peter A Nigrovic; Pui Y Lee
Journal:  Clin Immunol       Date:  2020-04-07       Impact factor: 3.969

Review 3.  A Spotlight on Drug-Induced Vasculitis.

Authors:  Kinanah Yaseen; Alana Nevares; Hiromichi Tamaki
Journal:  Curr Rheumatol Rep       Date:  2022-09-21       Impact factor: 4.686

Review 4.  Vasculitis Pathogenesis: Can We Talk About Precision Medicine?

Authors:  Seza Ozen; Ezgi Deniz Batu
Journal:  Front Immunol       Date:  2018-08-14       Impact factor: 7.561

5.  Association of serum high mobility group box 1 levels with disease activity and renal involvement in patients with systemic vasculitis.

Authors:  Bin Zhu; Nanfang Li; Qing Zhu; Ting Wu; Mulalibieke Heizati; Guoliang Wang; Xiaoguang Yao; Qin Luo; Shasha Liu; Shanshan Liu; Jing Hong
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

6.  Spontaneous Retroperitoneal Hematoma: A Rare Presentation of Polyarteritis Nodosa.

Authors:  Asad Ullah; Asghar Marwat; Krithika Suresh; Ahmed Khalil; Saba Waseem
Journal:  J Investig Med High Impact Case Rep       Date:  2019 Jan-Dec

Review 7.  CD8+ T Cells in GCA and GPA: Bystanders or Active Contributors?

Authors:  Rosanne D Reitsema; Annemieke M H Boots; Kornelis S M van der Geest; Maria Sandovici; Peter Heeringa; Elisabeth Brouwer
Journal:  Front Immunol       Date:  2021-03-18       Impact factor: 7.561

Review 8.  Spectrum of Large and Medium Vessel Vasculitis in Adults: Primary Vasculitides, Arthritides, Connective Tissue, and Fibroinflammatory Diseases.

Authors:  Luca Seitz; Pascal Seitz; Roxana Pop; Fabian Lötscher
Journal:  Curr Rheumatol Rep       Date:  2022-09-27       Impact factor: 4.686

9.  Polyarteritis nodosa with perirenal hematoma due to the rupture of a renal artery aneurysm.

Authors:  Taro Miyagawa; Yasunori Iwata; Megumi Oshima; Hisayuki Ogura; Koichi Sato; Shiori Nakagawa; Yuta Yamamura; Shinji Kitajima; Tadashi Toyama; Akinori Hara; Satoshi Kokubo; Norihiko Sakai; Miho Shimizu; Kengo Furuichi; Takashi Wada
Journal:  CEN Case Rep       Date:  2020-11-11

Review 10.  Remission of Angiographically Confirmed Minocycline-induced Renal Polyarteritis Nodosa: A Case Report and Literature Review.

Authors:  Kenichi Yokota; Isao Kurihara; Toshifumi Nakamura; Seishi Nakatsuka; Kazutoshi Miyashita; Sakiko Kobayashi; Ayano Murai-Takeda; Masakatsu Sone; Hiroshi Itoh
Journal:  Intern Med       Date:  2021-06-26       Impact factor: 1.271

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.